Clinical Trial Update: Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) [Phase 1]

View source ↗

Summary

A Phase I dose-escalation safety study of RetinoStat for advanced age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• RetinoStat

Snippet

Sponsor: Oxford BioMedica | Conditions: Age Related Macular Degeneration | Phase 1 | Status: COMPLETED